<?xml version="1.0" encoding="UTF-8"?>
<p>Neutrophils are crucial for the innate immunity. G-CSF is therefore used in neutropenic patients as a preventive treatment to avoid infections. Still, a study with transplant recipients reported that preventive G-CSF treatment did not alter infection-related mortality in these patients (
 <xref rid="B51" ref-type="bibr">51</xref>). While this supports the relevance of reduced neutrophil functionality, i.e., the ability to reach the site of infection 
 <italic>in vivo</italic> by chemotaxis, others described an unchanged infection risk in G-CSF-treated HSC donors (
 <xref rid="B52" ref-type="bibr">52</xref>). Taken together, this suggests a potential compensation by number if neutrophil functionality is reduced.
</p>
